# Defining the Role of Palliative carE for Patients With Hematologic Malignancies Undergoing Adoptive CEllular Therapy

> **NCT05646576** · NA · RECRUITING · sponsor: **Massachusetts General Hospital** · enrollment: 90 (estimated)

## Conditions studied

- Hematologic Malignancy
- Blood Cancer
- Lymphoma
- Leukemia
- Multiple Myeloma

## Interventions

- **BEHAVIORAL:** Palliative Care
- **BEHAVIORAL:** Usual Care

## Key facts

- **NCT ID:** NCT05646576
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-12-30
- **Primary completion:** 2026-12-30
- **Final completion:** 2027-04-01
- **Target enrollment:** 90 (ESTIMATED)
- **Last updated:** 2026-04-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05646576

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05646576, "Defining the Role of Palliative carE for Patients With Hematologic Malignancies Undergoing Adoptive CEllular Therapy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05646576. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*